News
Abzena bolsters senior leadership team with two key appointments
Abzena, the leading end-to-end integrated CDMO for Antibody Drug Conjugates (ADCs) and complex biologic molecules, has strengthened its senior leadership team with the appointment of Joe Principe as Chief Commercial Officer, and Matthew Pinkston as Vice President, Program Management.
Having...
IT & Data Management
Stem Cell Robots For Cell Therapy To Be Trialled By MHRA, UK
The Medicines and Healthcare Products Regulatory Agency's (MHRA) UK stem cell bank is trailing a new and innovative robot that would grow stem cells.
The MHRA's UK Stem Cell Bank is examining a stem cell propagation robot over a period...
Drug Research
Medicine Price Negotiations – Pathways Chalked By The CMS
The Centers for Medicare & Medicaid Services issued preliminary instructions on March 15 on how it intends to negotiate medication pricing under Medicare, a power provided to the agency by 2022’s Inflation Reduction Act.
According to CMS officials, the clinical...
Drug Research
Double The Drugs For Price Negotiation, Says President Biden
President Joe Biden is looking to double the number of medicines that Medicare can help negotiate rates for and thereby enable the government to start those discussions more quickly, as per a budget proposal for 2024 that was released...
Clinical Trials
4-Year Study On Cystic Fibrosis Patients Shows Efficacy
The combination of modulator therapies tezacaftor (TEZ) and ivacaftor (IVA) for cystic fibrosis (CF) has shown long-term safety as well as clinical benefit in a trial that lasted four years.
Both the CF modulators were assessed across the age group...
BioPharma
New UK Biotech Centres To Boost Cell And Gene Therapies
The National Health Service Blood and Transplant from the UK, which takes care of blood as well as platelet donations as well as organ, stem cell, and tissue transplants in the country, has come up with a new clinical...
Clinical Trials
$15m Mitochondrial Clinical Trial Headed by Australian University
Almost 50 children in Australia are born every year with a devastating mitochondrial disease that has an expected lifespan of just 5 years. In a first in Australia, the Medical Research Future Fund has gone on to announce $15...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read